Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
1,560
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages

Bradley K. Ackersona Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0816-7345View further author information
ORCID Icon,
Katia J. Bruxvoorta Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA;b Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USAView further author information
,
Lei Qiana Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Lina S. Sya Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Sijia Qiua Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Julia E. Tuberta Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Gina S. Leea Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Jennifer H. Kua Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Ana Floreaa Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Yi Luoa Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Radha Bathalaa Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Julie Sterna Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Soon K. Choia Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Harpreet S. Takhara Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Michael Aragonesa Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USAView further author information
,
Morgan A. Marksc Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USAView further author information
,
Evan J. Andersonc Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USAView further author information
,
Cindy Ke Zhouc Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USAView further author information
,
Tianyu Sunc Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USAView further author information
,
Carla A. Talaricoc Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA;d Epidemiology, AstraZeneca, Gaithersburg, MD, USAView further author information
&
Hung Fu Tsenga Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA;e Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6184-6534View further author information
ORCID Icon show all
Article: 2335052 | Received 16 Jan 2024, Accepted 22 Mar 2024, Published online: 04 Apr 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.